{"id":50446,"date":"2022-11-03T15:02:32","date_gmt":"2022-11-03T14:02:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/"},"modified":"2022-11-03T15:02:32","modified_gmt":"2022-11-03T14:02:32","slug":"vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/","title":{"rendered":"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response"},"content":{"rendered":"
\n

\nDatabase and resources will help improve treatment and outcomes<\/i>\n<\/p>\n

BURLINGTON, Vt.–(BUSINESS WIRE)–The <\/strong>Vermont Department of Health has launched <\/i>a first-of-a-kind program to support healthcare professionals with timely information on disease diagnosis, testing, treatment and patient education resources \u2014 improving public health response statewide.\n<\/p>\n

<\/a><\/p>\n

\nThe Clinician Support Initiative<\/a> <\/i>provides access to a vast collection of images and clinical information about public health threats, including hMPXV (human monkeypox virus), COVID-19 and Lyme disease. Available on the web or through an app, these tools help improve the speed and accuracy of diagnosis and facilitate the timely reporting to public health for diseases of public health significance.\n<\/p>\n

\nThese resources are being made available to Vermont healthcare professionals in partnership with VisualDx<\/a>, a healthcare informatics company based in Rochester, NY. A phased rollout is currently underway, and all Vermont medical professionals can expect access by the end of the year.\n<\/p>\n

\nThe Clinician Support Initiative aims to remove barriers between public health goals and the time-strapped medical professional by delivering time-sensitive, clinically relevant information critical to diagnosing and treating common and rare conditions. This will improve Vermont\u2019s readiness for emerging infectious diseases in the wake of recent and ongoing public health emergencies, such as the COVID-19 pandemic and hMPXV.\n<\/p>\n

\n\u201cOne of our longstanding priorities has been to better integrate public health and primary care, and with the right tools we can do just that,\u201d said Health Commissioner Mark Levine, MD. \u201cThis initiative brings public health best practices right to the real-time clinician\/patient relationship, enabling quick and easy reporting of important conditions, along with access to Vermont-specific information and guidance,\u201d said Dr. Levine.\n<\/p>\n

\nDr. Levine added that the need for these connections has never been so vital, as COVID-19, pediatric hepatitis, meningococcal disease, hMPXV and other diseases spread nationally and globally.\n<\/p>\n

\n\u201cClinicians are experiencing firsthand the diagnostic and treatment challenges that novel or rare diseases present, including the need to stop the spread of misinformation,\u201d Dr. Levine said. \u201cDiagnostic tools and educational resources that clinicians can share with patients are integral to achieving our shared mission of driving better care and public health.\u201d\n<\/p>\n

\nHealthcare providers can also regularly use the platform’s medical image library and patient information handouts to strengthen the patient-provider relationship and improve patient adherence to treatment plans.\n<\/p>\n

\n\u201cAs a team of practicing physicians, we understand the daily challenges that professionals face. In addition to staff shortages and other constant stressors, clinicians are navigating the shifting landscape of infectious disease,\u201d said Art Papier, MD, CEO of VisualDx, and alumnus of the University of Vermont College of Medicine, where he earned his medical credentials. \u201cOur mission is to provide medical professionals with tools and resources to augment decision-making and improve patient health. We believe the Health Department\u2019s Clinician Support Initiative will become a national model.\u201d\n<\/p>\n

\nFor more information about the initiative and how to enroll, visit visualdx.com\/vdhcsi<\/a>.\n<\/p>\n

\nAbout Vermont Department of Health<\/strong>\n<\/p>\n

\nWe have been the state\u2019s public health agency for more than 130 years, working every day to protect and promote the health of Vermonters.
\n
Visit healthvermont.gov<\/a> \u2013 Join us @healthvermont on Facebook<\/a>, Twitter<\/a>, Instagram<\/a>, YouTube<\/a>\n<\/p>\n

\nAbout VisualDx<\/b>\n<\/p>\n

\nVisualDx is an award-winning diagnostic clinical decision support system that has become the standard medical professional resource at more than 50% of U.S. medical schools and more than 2,300 hospitals and clinics worldwide. VisualDx combines problem oriented clinical search with the world’s best curated medical image library, plus medical knowledge from experts and sophisticated machine learning algorithms to help with differential diagnosis, variation, treatment, and patient communication. Our mission is to improve healthcare decision making and reduce diagnostic errors. Learn more at www.visualdx.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/strong>:
\n
Ben Truman \u2502 Vermont Department of Health
\n
802-316-2117 \/ 802-863-7281
\n
bennett.truman@vermont.gov<\/a><\/p>\n

Sean Chase \u2502 Aria Marketing for VisualDx
\n
603-307-9428
\n
schase@ariamarketing.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Database and resources will help improve treatment and outcomes BURLINGTON, Vt.–(BUSINESS WIRE)–The Vermont Department of Health has launched a first-of-a-kind program to support healthcare professionals with timely information on disease diagnosis, testing, treatment and patient education resources \u2014 improving public health response statewide. The Clinician Support Initiative provides access to a vast collection of images … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50446","6":"format-standard","7":"category-industry"},"yoast_head":"\nVermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Database and resources will help improve treatment and outcomes BURLINGTON, Vt.–(BUSINESS WIRE)–The Vermont Department of Health has launched a first-of-a-kind program to support healthcare professionals with timely information on disease diagnosis, testing, treatment and patient education resources \u2014 improving public health response statewide. The Clinician Support Initiative provides access to a vast collection of images ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-03T14:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221103005234\/en\/1623293\/21\/Vermont_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response\",\"datePublished\":\"2022-11-03T14:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/\"},\"wordCount\":645,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221103005234\\\/en\\\/1623293\\\/21\\\/Vermont_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/\",\"name\":\"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221103005234\\\/en\\\/1623293\\\/21\\\/Vermont_Logo.jpg\",\"datePublished\":\"2022-11-03T14:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221103005234\\\/en\\\/1623293\\\/21\\\/Vermont_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221103005234\\\/en\\\/1623293\\\/21\\\/Vermont_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/","og_locale":"en_US","og_type":"article","og_title":"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response - Pharma Trend","og_description":"Database and resources will help improve treatment and outcomes BURLINGTON, Vt.–(BUSINESS WIRE)–The Vermont Department of Health has launched a first-of-a-kind program to support healthcare professionals with timely information on disease diagnosis, testing, treatment and patient education resources \u2014 improving public health response statewide. The Clinician Support Initiative provides access to a vast collection of images ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-03T14:02:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221103005234\/en\/1623293\/21\/Vermont_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response","datePublished":"2022-11-03T14:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/"},"wordCount":645,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221103005234\/en\/1623293\/21\/Vermont_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/","url":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/","name":"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221103005234\/en\/1623293\/21\/Vermont_Logo.jpg","datePublished":"2022-11-03T14:02:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221103005234\/en\/1623293\/21\/Vermont_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221103005234\/en\/1623293\/21\/Vermont_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50446"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50446\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}